CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Biomed Lublin Wytwornia Surowic I Szczepionek SA Company Snapshot
Biomed Lublin Wytwornia Surowic I Szczepionek SA operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biomed Lublin Wytwornia Surowic I Szczepionek SA with three other pharmaceutical manufacturers in Europe: Medincell SA of France (2017 sales of 8.53 million Euro [US$9.67 million] ), Transgene of France (7.46 million Euro [US$8.45 million] of which 72% was Research & Development Tax Credit), and Curasan AG which is based in Germany (6.80 million Euro [US$7.70 million] ).

Sales Analysis. Biomed Lublin Wytwornia Surowic I Szczepionek SA reported sales of 31.40 million Polish New Zlotys (US$8.30 million) for the year ending December of 2017. This represents a decrease of 13.6% versus 2016, when the company's sales were 36.34 million Polish New Zlotys. Contributing to the drop in overall sales was the 93.6% decline in Traditional Segment, from 27.61 million Polish New Zlotys to 1.78 million Polish New Zlotys. . However, these declines were partially offset by the increase in sales of Plasma Segment (up 239.5% to 29.63 million Polish New Zlotys) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Biomed Lublin Wytwornia Surowic I Szczepionek SA
  Stock Performance Chart for Biomed Lublin Wytwornia Surowic I Szczepionek SA
 
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): 1.07
(Figures in Polish New Zlotys)
1 Week -6.1%   13 Weeks -7.0%  
4 Weeks -9.3%   52 Weeks -14.4%  
 
Biomed Lublin Wytwornia Surowic I Szczepionek SA Key Data:
  Ticker: BML Country: Poland
  Exchanges: WAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 31,404,000
(Year Ending Jan 2018).
Employees: 211
  Currency: Polish New Zlotys Market Cap: 66,618,639
  Fiscal Yr Ends: December Shares Outstanding: 62,260,410
  Share Type: Akcje Closely Held Shares: 28,699,602
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.